Impact of a COVID-19 Outbreak in an Elderly Care Home After Primary Vaccination
Overview
Authors
Affiliations
Elderly care home residents are particularly vulnerable to COVID-19 due to immune-senescence, pre-existing medical conditions, and the risk of transmission from staff and visitors. This study aimed to describe the outcomes of a COVID-19 outbreak in a long-term care facility for elderly persons following the initial vaccination. A single-center, retrospective, observational design was used to analyze the variables associated with hospitalization and death rate by logistic regression. Adjusted odds ratios (aOR) and their 95% confidence intervals (CI) were calculated. Sixty-eight residents received the first dose of the COVID-19 vaccine. Despite being negative six days after vaccination, the performance of a second test 4 days later revealed 51 positives (75.0%) among residents and 18 among workers (56.3%). A total of 65 of the 68 residents (95.58%) had positive results with symptoms, whereas 34.9% required hospitalization, and 25.8% died. The best-fitting model to explain the distribution of cases reflects three points at the time of infection.. The time from vaccination to symptom onset explains the hospitalization and mortality rates since a day elapsed halves the risk of hospitalization (aOR = 0.57; CI = 0.38-0.75) and the risk of death by a quarter (aOR = 0.74; CI = 0.63-0.88). Nursing homes present an elevated risk of transmission and severity of SARS-CoV-2 infection. Although vaccination reduces the risk of hospitalization and death, extreme prevention and control measures are essential in these institutions despite the high vaccination coverage.
Understanding the impact of COVID-19 on quality of life using surveys and Mendelian randomization.
Jiang K, Ji H, Ma L, Zhao Z, Zhao Y, Feng J Sci Rep. 2024; 14(1):30929.
PMID: 39730560 PMC: 11680575. DOI: 10.1038/s41598-024-81579-5.
Gasco-Laborda J, Gil-Fortuno M, Tirado-Balaguer M, Meseguer-Ferrer N, Sabalza-Baztan O, Perez-Olaso O Epidemiologia (Basel). 2024; 5(4):658-668.
PMID: 39449389 PMC: 11503345. DOI: 10.3390/epidemiologia5040046.
Hashan M, Smoll N, Chapman G, King C, Walker J, Kirk M BMJ Open. 2024; 14(3):e073555.
PMID: 38485480 PMC: 10941149. DOI: 10.1136/bmjopen-2023-073555.